Acadia Pharmaceuticals (ACAD) Net Cash Flow (2010 - 2026)
Acadia Pharmaceuticals' quarterly Net Cash Flow came in at $104.5 million in Q1 2026, up 202.56% year-on-year from $34.5 million in Q1 2025, and up 227.53% quarter-over-quarter from -$81.9 million in Q4 2025.
Acadia Pharmaceuticals has reported Net Cash Flow for 17 years, with the latest figure at $104.5 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 202.56% year-over-year to $104.5 million; the trailing twelve-month figure through Mar 2026 stood at $63.5 million (up 295.74% YoY), and the FY2025 full-year result was -$142.8 million, down 206.58% from the prior year.
- Net Cash Flow for Q1 2026 stood at $104.5 million, up from -$81.9 million in the prior quarter.
- The five-year high for Net Cash Flow was $176.1 million in Q1 2023, with the low at -$180.6 million in Q2 2023.
- Average Net Cash Flow over 5 years is $8.1 million, with a median of $4.4 million recorded in 2025.
- Year-over-year, Net Cash Flow soared 366.79% in 2022 and tumbled 733.51% in 2025.
- Tracing ACAD's Net Cash Flow over 5 years: stood at -$40.0 million in 2022, then soared by 326.26% to $90.5 million in 2023, then jumped by 81.82% to $164.5 million in 2024, then sank by 149.81% to -$81.9 million in 2025, then surged by 227.53% to $104.5 million in 2026.
- The last three Net Cash Flow figures came in at $104.5 million (Q1 2026), -$81.9 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | 104.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.49 Mn |
| Mar 31, 2026 | 104.49 Mn |
| Dec 31, 2025 | -81.93 Mn |
| Dec 31, 2025 | -81.93 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Jun 30, 2025 | 36.62 Mn |
| Jun 30, 2025 | 36.62 Mn |
| Mar 31, 2025 | -101.89 Mn |
| Mar 31, 2025 | -101.89 Mn |
| Dec 31, 2024 | 164.50 Mn |
| Dec 31, 2024 | 164.50 Mn |
| Sep 30, 2024 | -18.94 Mn |
| Sep 30, 2024 | -18.94 Mn |
| Jun 30, 2024 | -27.61 Mn |
| Jun 30, 2024 | -27.61 Mn |
| Mar 31, 2024 | 16.08 Mn |
| Mar 31, 2024 | 16.08 Mn |
| Dec 31, 2023 | 90.48 Mn |
| Dec 31, 2023 | 90.48 Mn |
| Sep 30, 2023 | -12.09 Mn |
| Sep 30, 2023 | -12.09 Mn |
| Jun 30, 2023 | -180.60 Mn |
| Jun 30, 2023 | -180.60 Mn |
| Mar 31, 2023 | 176.05 Mn |
| Mar 31, 2023 | 176.05 Mn |
| Dec 31, 2022 | -39.99 Mn |
| Dec 31, 2022 | -39.99 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | -65.09 Mn |
| Jun 30, 2022 | -65.09 Mn |
| Mar 31, 2022 | 57.48 Mn |
| Mar 31, 2022 | 57.48 Mn |
| Dec 31, 2021 | 52.79 Mn |
| Dec 31, 2021 | 52.79 Mn |
| Sep 30, 2021 | -172.32 Mn |
| Sep 30, 2021 | -172.32 Mn |
| Jun 30, 2021 | -37.53 Mn |
| Jun 30, 2021 | -37.53 Mn |
| Mar 31, 2021 | -21.55 Mn |
| Mar 31, 2021 | -21.55 Mn |
| Dec 31, 2020 | -126.32 Mn |
| Dec 31, 2020 | -126.32 Mn |
| Sep 30, 2020 | 141.92 Mn |
| Sep 30, 2020 | 141.92 Mn |
| Jun 30, 2020 | 137.38 Mn |
| Jun 30, 2020 | 137.38 Mn |
| Mar 31, 2020 | -15.64 Mn |
| Mar 31, 2020 | -15.64 Mn |
| Dec 31, 2019 | -195.79 Mn |
| Dec 31, 2019 | -195.79 Mn |
| Sep 30, 2019 | 311.04 Mn |
| Sep 30, 2019 | 311.04 Mn |
| Jun 30, 2019 | -23.12 Mn |
| Jun 30, 2019 | -23.12 Mn |
| Mar 31, 2019 | -37.24 Mn |
| Mar 31, 2019 | -37.24 Mn |
| Dec 31, 2018 | 72.58 Mn |
| Dec 31, 2018 | 72.58 Mn |
| Sep 30, 2018 | -10.29 Mn |
| Sep 30, 2018 | -10.29 Mn |
| Jun 30, 2018 | -41.86 Mn |
| Jun 30, 2018 | -41.86 Mn |
| Mar 31, 2018 | 47.26 Mn |
| Mar 31, 2018 | 47.26 Mn |
| Dec 31, 2017 | -43.20 Mn |
| Dec 31, 2017 | -43.20 Mn |
| Sep 30, 2017 | -31.17 Mn |
| Sep 30, 2017 | -31.17 Mn |
| Jun 30, 2017 | -13.59 Mn |
| Jun 30, 2017 | -13.59 Mn |
| Mar 31, 2017 | -6.14 Mn |
| Mar 31, 2017 | -6.14 Mn |
| Dec 31, 2016 | 11.94 Mn |
| Dec 31, 2016 | 11.94 Mn |
| Sep 30, 2016 | 21.91 Mn |
| Sep 30, 2016 | 21.91 Mn |
| Jun 30, 2016 | -43.45 Mn |
| Jun 30, 2016 | -43.45 Mn |
| Mar 31, 2016 | 73.08 Mn |
| Mar 31, 2016 | 73.08 Mn |
| Dec 31, 2015 | 31.34 Mn |
| Dec 31, 2015 | 31.34 Mn |
| Sep 30, 2015 | -22.41 Mn |
| Sep 30, 2015 | -22.41 Mn |
| Jun 30, 2015 | 16.79 Mn |
| Jun 30, 2015 | 16.79 Mn |
| Mar 31, 2015 | 14.57 Mn |
| Mar 31, 2015 | 14.57 Mn |
| Dec 31, 2014 | 25.48 Mn |
| Dec 31, 2014 | 25.48 Mn |
| Sep 30, 2014 | 22.67 Mn |
| Sep 30, 2014 | 22.67 Mn |
| Jun 30, 2014 | -82.76 Mn |
| Jun 30, 2014 | -82.76 Mn |
| Mar 31, 2014 | 84.75 Mn |
| Mar 31, 2014 | 84.75 Mn |
| Dec 31, 2013 | -95,000.00 |
| Dec 31, 2013 | -95,000.00 |
| Sep 30, 2013 | -12.44 Mn |
| Sep 30, 2013 | -12.44 Mn |
| Jun 30, 2013 | 5.81 Mn |
| Jun 30, 2013 | 5.81 Mn |
| Mar 31, 2013 | -39.46 Mn |
| Mar 31, 2013 | -39.46 Mn |
| Dec 31, 2012 | 49.88 Mn |
| Dec 31, 2012 | 49.88 Mn |
| Sep 30, 2012 | -1.19 Mn |
| Sep 30, 2012 | -1.19 Mn |
| Jun 30, 2012 | 3.65 Mn |
| Jun 30, 2012 | 3.65 Mn |
| Mar 31, 2012 | -1.33 Mn |
| Mar 31, 2012 | -1.33 Mn |
| Dec 31, 2011 | -1.43 Mn |
| Dec 31, 2011 | -1.43 Mn |
| Sep 30, 2011 | 296,000.00 |
| Sep 30, 2011 | 296,000.00 |
| Jun 30, 2011 | 1.19 Mn |
| Jun 30, 2011 | 1.19 Mn |
| Mar 31, 2011 | -32,000.00 |
| Mar 31, 2011 | -32,000.00 |
| Dec 31, 2010 | -2.80 Mn |
| Dec 31, 2010 | -2.80 Mn |
| Sep 30, 2010 | 739,000.00 |
| Sep 30, 2010 | 739,000.00 |